Clinical trial Recruiting at 1 site Observational Ages 18 to 89 Men only

Testosterone and blood vessel health after spinal cord injury

Official title: Testosterone Deficiency and Endothelial Dysfunction in Spinal Cord Injury Related Cardiovascular Disease Mechanistic Insights and Therapeutic Prospects

Run by Craig Hospital · NCT07227740 · Data updated 2026-11-12

This research tests if low testosterone in men with recent motor-complete paraplegia is linked to poorer blood vessel function and higher blood markers of endothelial injury.

More Spinal Cord Injuries trials

Quick facts

Study typeObservational
Ages18 Years to 89 Years
SexMen only
Enrollment48 (estimated)
SponsorCraig Hospital
Academic / other
Locations1 site (Englewood, Colorado)
StatusRecruiting
StartedJuly 15, 2025
Main results expectedJuly 14, 2028
Study endsJuly 14, 2028
Registry record updatedNovember 21, 2025
Trial IDNCT07227740 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Men aged 18–89 with motor-complete paraplegia (NLI T3 or below) within 6 months of injury who can have blood tests to determine testosterone status are the intended participants.

Probably not a fit

People with overt cardiovascular disease, recent surgery or active infection, current or recent tobacco use, use of cardiovascular-acting medications, women, those with incomplete or chronic (>6 months) injuries, or those with contraindications to intra-arterial procedures are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional study will enroll 48 men with subacute (<6 months) motor-complete paraplegia (neurological level T3 or below), with 24 participants who have low testosterone (<300 ng/dL) and 24 with normal levels. Investigators will measure endothelium-dependent vasodilation and t-PA release using intra-arterial infusions of vasoactive agents while recording forearm blood flow, and will analyze endothelial cell–derived microvesicles and other blood biomarkers. Some participants will receive intra-arterial vitamin C to probe the role of oxidative stress in vascular responses. The study compares vascular function and circulating markers between the low-T and normal-T groups to see if testosterone deficiency helps explain early vascular risk after SCI.

Why it matters

Potential benefit: If successful, this work could point to testosterone as a modifiable factor and identify blood tests that flag early vascular trouble so heart attacks and strokes might be prevented in people with SCI.

How similar studies have gone: Prior studies have documented endothelial dysfunction and a high prevalence of low testosterone after SCI, but few have directly compared vascular function by testosterone status or used endothelial microvesicles as blood markers, so this approach is partly novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between ages 18-89 years of age
* Male Sex
* History of motor complete (AIS A/B) paraplegia (NLI T3 or Below)
* Time since injury \<6 months at time of enrollment (Subacute injury)
* Testosterone Deficiency defined as \< 300ng/dL

Exclusion Criteria:

* Overt cardiovascular disease assessed by a) medical history, b) physical examination c) electrocardiogram
* Anaphylaxis to betadine, lidocaine, iodine
* Active infection at time of enrollment.
* Recent surgery (\<1 month) at time of enrollment.
* History smoking tobacco (currently or in the past 12 months)
* History of more than low-risk history of alcohol consumption
* History of drug abuse
* History of use of cardiovascular-acting (i.e. statins, beta-blockers) therapeutics
* History of other health habits, medications, and supplements that could influence the outcome measures deemed by principal investigators and investigative team.

Where it's running

  • Craig Hospital
    Englewood, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.